FdaApplication

NDA 022343

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAUROBINDO PHARMA LTD
application_typeNDA
approval_date2018-08-15

Products (1)

ProductActive ingredientStrengthDosage form
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATEEFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE600MG;300MG;300MGTABLET;ORAL

1 product